These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin. Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154 [TBL] [Abstract][Full Text] [Related]
25. [Therapy of dyslipidemia in post-infarction: state of the art]. Borgia MC; Nardi M; Da Ros S; Castellano V Clin Ter; 2007; 158(6):523-32. PubMed ID: 18265719 [TBL] [Abstract][Full Text] [Related]
26. Combination therapy with statins and omega-3 fatty acids. Nambi V; Ballantyne CM Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515 [TBL] [Abstract][Full Text] [Related]
27. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
28. [Drug therapy of hypercholesterolemia. Treatment of hypercholesterolemia in adults--a Norwegian therapeutic program 1988]. Ose L; Blomhoff JP; Torsvik H Tidsskr Nor Laegeforen; 1989 Mar; 109(7-8):850-2. PubMed ID: 2705170 [TBL] [Abstract][Full Text] [Related]
29. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice]. Olsson AG; Nilsson PM Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786 [No Abstract] [Full Text] [Related]
30. Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy. Miettinen TA Int J Clin Pract; 2001 Dec; 55(10):710-6. PubMed ID: 11777299 [TBL] [Abstract][Full Text] [Related]
31. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs. Illingworth DR; Bacon S Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189 [TBL] [Abstract][Full Text] [Related]
32. Lower cholesterol without statins. Options are available. Mayo Clin Health Lett; 2006 May; 24(5):4-5. PubMed ID: 16703660 [No Abstract] [Full Text] [Related]
33. LDL-Cholesterol is the King. Goumas GS Angiology; 2009; 60(3):387-8. PubMed ID: 19497926 [No Abstract] [Full Text] [Related]
34. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins? Goumas GS Angiology; 2009; 60(1):93-8. PubMed ID: 19019838 [TBL] [Abstract][Full Text] [Related]
35. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy. Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691 [TBL] [Abstract][Full Text] [Related]
36. [Trends toward development of other novel antihyperlipidemic drugs]. Yamashita S Nihon Rinsho; 2002 May; 60(5):984-92. PubMed ID: 12030003 [TBL] [Abstract][Full Text] [Related]
37. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins. Geiss HC; Otto C; Parhofer KG Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435 [TBL] [Abstract][Full Text] [Related]
38. Other therapies for reducing low-density lipoprotein cholesterol: medications in development. Stein EA Endocrinol Metab Clin North Am; 2009 Mar; 38(1):99-119. PubMed ID: 19217514 [TBL] [Abstract][Full Text] [Related]
39. [On the current debate on lowering LDL cholesterol with ezetimibe]. Breuer HW Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008 [No Abstract] [Full Text] [Related]